C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
IGC Equity

IGC

OTCMKTS · IGC

$0.27
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
40/100 composite
Fundamentals38
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

India Globalization Capital carries a Neutral rating with three-out-of-five conviction, reflecting a composite score of 40 and an uneven pillar profile. Regulatory is the strongest contribution at 49, supported by an 80 enforcement subscore and a 50 jurisdiction assessment. Market stands at 40 despite the absence of an available quote, while fundamentals trail at 38 as gross-margin strength is overwhelmed by operating losses and limited scale. Editorial ranks lowest at 30, consistent with no newsroom or brief activity in CIN newsroom coverage. The resulting band appropriately balances a comparatively stable regulatory profile against stretched financial condition, weak profitability, sparse filing visibility, and minimal coverage momentum.

Licensed fundamentals data show year-over-year revenue contracting by approximately 3.9%, leaving the revenue-growth subscore near 46. Gross margin remains the clearest operating positive at roughly 46.2%, producing a strong 77 subscore, but the operating margin is deeply negative at about 723% below breakeven and receives no subscore contribution. EBITDA is negative by approximately $7.5 million, while reported net income is zero; neither figure offsets the stretched classification. A market capitalization near $28.4 million contributes a low scale subscore of roughly 18, and the cash-burn ratio of approximately 26.5% supports only a 41-level runway assessment. Primary regulatory filings show no recorded filing date and no events across either the prior 90-day or 180-day periods, producing a cadence subscore of 25. Institutional pricing feeds also provide no available quote, constraining market-pillar confirmation.

The clearest forward catalyst sits within the regulatory pillar, where the absence of enforcement hits already supplies the company’s strongest individual driver. That strength remains incomplete because filing cadence materially lags the enforcement contribution. A timely primary regulatory filing with substantive operating and financial detail would lift transparency, refresh the stale cadence signal, and enable clearer assessment of revenue direction, margin durability, and the stretched financial position. Such an event would carry greater rating relevance than an isolated coverage item because regulatory already leads the pillar set and has the widest identifiable route to incremental improvement. The single most important signal to watch is the arrival of a fresh primary regulatory filing that restores cadence and updates the financial record.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
10224 FALLS ROAD, POTOMAC, MD, 20854
Phone
301-529-4996
CEO
Ram Mukunda
CFO
Claudia Grimaldi
SEC CIK
1326205
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$28.4M
Enterprise value
$29.1M
Price to book
4.64
Price to sales
25.67
EV / EBITDA
27.31
Revenue (TTM)
$1.1M
Gross profit (TTM)
$511K
EBITDA
$-7.5M
Operating margin
-722.7%
Profit margin
0.0%
Rev growth YoY
-3.9%
Return on equity
-83.3%
Return on assets
-50.3%
EPS (TTM)
$-0.06
EPS est. current year
$-0.08
Wall St. target price
$4.25
Shares outstanding
104.4M
Insider ownership
13.4%
Institutional ownership
21.7%
Beta
0.46
Full-time employees
70
GICS sector
Healthcare
GICS industry
Biotechnology
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for IGC (IGC)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for IGC (IGC), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for IGC are maintained by Cannabis Investor News and refreshed throughout the trading day.